WHO, ECDC Report Rising Hospital Bacteria Resistance
A joint analysis of 2025 laboratory findings across the WHO European Region flags high resistance in key hospital-acquired bacteria.
Updated on Nov. 18, 2026 in Diseases — General

Live Poll
Do you trust your local hospitals to protect patients from drug-resistant infections?
The World Health Organization and the European Centre for Disease Prevention and Control released an analysis of 2025 laboratory findings on antibiotic resistance in bacteria found in hospitals across the WHO European Region. Resistance in several bacteria reached at least 50% in many reporting countries.
Why it matters
Bacteria that resist last-line antibiotics limit treatment options for hospital patients and complicate routine care. The findings show the problem is widespread across the region, though coverage is not complete.
The figures come from laboratory testing of bacterial samples reported through two surveillance networks, one covering the European Union and European Economic Area and one covering other participating countries in the region. Because laboratory coverage and sample representativeness differ and the findings do not include every country, the country counts describe only the reporting countries.
The players
World Health Organization (WHO)
The United Nations agency responsible for international public health, which coordinates global surveillance of infectious diseases and antimicrobial resistance.
European Centre for Disease Prevention and Control (ECDC)
The European Union agency that monitors infectious diseases and supports member states with surveillance and outbreak response.
The details
The joint executive summary draws on laboratory results from 2025 that were reported through two surveillance networks using compatible methods. The analysis tracks resistance in Klebsiella pneumoniae and Acinetobacter, two bacteria that often cause infections in hospital settings.
Timeline
2025: Laboratory findings analyzed in the report were collected.
November 18, 2026: WHO and ECDC released the analysis.
Health Landscape
The report extends the joint WHO and ECDC European antimicrobial resistance surveillance network's ongoing annual reporting by publishing 2025 resistance levels across participating countries. It sits within a broader regional effort to track hospital-acquired bacteria that resist carbapenem antibiotics, a class often used as a last resort.
Patients admitted to hospitals may face infections that respond poorly to standard antibiotics, which can lengthen treatment and recovery. Clinicians often rely on laboratory testing to choose effective drugs, so patients may notice more testing before treatment begins.
The takeaway
Antibiotic resistance is a regional problem that spans many countries, so hospital infection control and careful antibiotic use matter everywhere. Staying current with surveillance reports helps show where resistance is rising fastest.
Further reading
Explore more on Diseases — General for background on how drug-resistant infections spread.
Source note: This article includes information reported by Okay News.
Live Poll
Do you trust your local hospitals to protect patients from drug-resistant infections?



